TESAMORELIN – 20MG

What Is Tesamorelin

Tesamorelin is a synthetic 44-amino-acid analog of human growth hormone-releasing hormone (GHRH) carrying a trans-3-hexenoic acid group at the N-terminus that protects it from DPP-IV cleavage. It binds the GHRH receptor on pituitary somatotropes and stimulates pulsatile release of the body’s own growth hormone instead of replacing GH directly. Researchers who buy tesamorelin often start with our CJC-1295 and Ipamorelin guide to see how GHRH analogs compare with ghrelin-receptor secretagogues.

Key Research Applications

·         Visceral adipose tissue: The most extensively documented tesamorelin endpoint, with CT-measured VAT reductions of roughly 15% across 26-week Phase 3 trials.

·         Hepatic fat and NAFLD models: Published 12-month data show a 37% relative reduction in liver fat fraction versus placebo.

·         GH/IGF-1 axis physiology: A clean tool for studying pulsatile GH secretion and physiologic, rather than supraphysiologic, IGF-1 elevation.

·         Cognitive aging research: Preliminary controlled data on executive function in older adults receiving GHRH analog protocols.